- Home
- NVAX vs DMLP Comparison
NVAX vs DMLP Comparison
Compare NVAX & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- DMLP
- Stock Information
- Founded
- NVAX 1987
- DMLP 2003
- Country
- NVAX United States
- DMLP United States
- Employees
- NVAX N/A
- DMLP N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- DMLP Oil & Gas Production
- Sector
- NVAX Health Care
- DMLP Energy
- Exchange
- NVAX Nasdaq
- DMLP Nasdaq
- Market Cap
- NVAX 1.3B
- DMLP 1.5B
- IPO Year
- NVAX 1995
- DMLP N/A
- Fundamental
- Price
- NVAX $8.17
- DMLP $29.64
- Analyst Decision
- NVAX Buy
- DMLP
- Analyst Count
- NVAX 6
- DMLP 0
- Target Price
- NVAX $17.83
- DMLP N/A
- AVG Volume (30 Days)
- NVAX 4.7M
- DMLP 157.9K
- Earning Date
- NVAX 05-09-2025
- DMLP 05-01-2025
- Dividend Yield
- NVAX N/A
- DMLP 10.87%
- EPS Growth
- NVAX N/A
- DMLP N/A
- EPS
- NVAX N/A
- DMLP 2.13
- Revenue
- NVAX $682,162,000.00
- DMLP $154,639,000.00
- Revenue This Year
- NVAX N/A
- DMLP N/A
- Revenue Next Year
- NVAX $15.02
- DMLP N/A
- P/E Ratio
- NVAX N/A
- DMLP $13.99
- Revenue Growth
- NVAX N/A
- DMLP N/A
- 52 Week Low
- NVAX $3.81
- DMLP $28.25
- 52 Week High
- NVAX $23.86
- DMLP $35.74
- Technical
- Relative Strength Index (RSI)
- NVAX 51.30
- DMLP 38.36
- Support Level
- NVAX $7.66
- DMLP $29.29
- Resistance Level
- NVAX $8.48
- DMLP $30.48
- Average True Range (ATR)
- NVAX 0.64
- DMLP 0.84
- MACD
- NVAX 0.08
- DMLP -0.02
- Stochastic Oscillator
- NVAX 71.43
- DMLP 44.27
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.